Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Transrectal ultrasound (TRUS) biopsy
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Isotope bone scan

• Treatment Facilities:
• Radical prostatectomy
• Robot assisted laparoscopic prostatectomy
• External beam radiotherapy (EBRT)
• Stereotactic body radiation therapy (SBRT)
• Chemotherapy

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Genetic counselling

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	487	925
Performance Status recorded	2%	42%
PSA completed	40%	52%
Gleason Score completed	N/A	N/A
TNM completed	25%	50%
Stage variable assigned	57%	68%

	Specialist MDT	National
No. of men with disease status determined	636	23477
Percentage of men diagnosed with metastatic disease	14%	17%
No. of men diagnosed with M1 (metastases)	88	N/A

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on Gleason score in the Rapid Cancer Registration Dataset

	Treatment Centre
No. of men who received radical prostatectomy (2020-2021)	91
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	11%
No. of men who received radical prostatectomy (2019)	144
Adjusted percentage of men experiencing at least one GU complication (%)	5%
No. of men who received radical radiotherapy (2019)	172
Adjusted percentage of men experiencing at least one GI complication (%)	8%